Speaker illustration

Doctor Moses Sghayyer

UAB Hospital, Birmingham (United States of America)

Member of:

European Society of Cardiology

PCSK-9 inhibitors vs. ezetimibe for secondary prevention: utilization disparities and clinical outcomes

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Pharmacotherapy to improve outcomes in coronary disease

Thumbnail